Ludwig Enterprises, Inc. (LUDG): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$4.39M
As of 2025-12-31
-$4.03M
As of 2026-03-31
2022-12-31: -$826.2K2023-12-31: -$1.46M2024-12-31: -$2.38M2025-12-31: -$4.39M-$4.39M
2022-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31-$4.39Mn/m2026-03-16, Balance as of period end
2024-12-31-$2.38Mn/m2026-03-16, Balance as of period end
2023-12-31-$1.46Mn/m2025-03-31, Balance as of period end
2022-12-31-$826.2Kn/a2024-04-16, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Ludwig Enterprises, Inc. (LUDG)2025-12-31-$4.39Mn/m
First Choice Healthcare Solutions, Inc. (FCHS)2025-12-31-$39.53Mn/m
Advanced Biomed Inc. (ADVB)2025-06-30$3.48M+109.1%
BioNexus Gene Lab Corp (BGLC)2025-12-31$8.61M+3.5%
Aclarion, Inc. (ACON)2025-12-31$12.84Mn/m
YD Bio Ltd (YDES)2025-12-31-$2.86Mn/m
American Shared Hospital Services (AMS)2025-12-31$27.69M-7.8%
Exagen Inc. (XGN)2025-12-31$17.45M+82.9%
Biodesix Inc (BDSX)2025-12-31-$2.46Mn/m

Compare LUDG, FCHS, ADVB, BGLC side by side · Screen every company in Services-Medical Laboratories ↗